by Don Gibbons | May 25, 2023
A recent Wall Street Journal article reminded me of the work of someone I came to know well while at the California Institute for Regenerative Medicine (CIRM): Jeanne Loring of the Scripps Research Institute. The article detailed a cell therapy for Parkinson’s Disease...
by Cal Strode | Mar 29, 2023
Few people have made bigger contributions to the Canadian regenerative medicine ecosystem than Dr. Peter Zandstra. He is co-founder of two companies advancing cutting-edge biotechnologies for therapeutic use (Notch Therapeutics and ExCellThera, both of which are...
by Kevin Robb | Oct 14, 2022
My heart is pounding, and my islets are secreting. Maybe it’s my fifth cup of sugary coffee kicking in, or maybe they’ve been inspired by the plenary session I’m recalling. While the former is more likely, I toy with the idea of the latter. In the “Clinical...
by Sara M. Nolte | Jul 14, 2022
Almost two years ago, I wrote a post about how scientists were looking for new immunotherapies to improve immunologically “cold” tumours’ responses to existing therapies. And while the findings of that article were very promising, tumour evasion of the immune system...
by Lyla El-Fayomi | Jul 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I sample the latest and greatest findings in recent press and package them into a single post. In this double issue, I cover a gene therapy for...
by Lyla El-Fayomi | May 10, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. April was full of great research and big...
Comments